Loading...
Evaluación del riesgo generada por un proceso regulatorio (RA)
  |  
last updated: 09 jul. 2026
Información general
Risk assessment of the PROTEQFLU Vaccine - Technical Opinion No. 5486/2017.
EN
08 jun. 2017
Información de la evaluación del riesgo
  • Proteqflu - equine influenza vaccine
    | Merial | Producción de compuestos médicos o farmacéuticos (humanos o animales) (Vacunas), Use as vaccine
ProteqFlu is a vaccine intended to protect domestic horses against equine influenza (H3N8).
EN
Metodología y puntos a considerar
There is no potential environmental hazard that can be identified by using the ProteqFlu vaccine.
EN
Safety studies were conducted on non-target species involving canaries, ducks, chickens, pigs, rats and guinea pigs and the results support the product's safety profile.
EN
There is no potential environmental hazard that can be identified by using the ProteqFlu vaccine.
EN
It is not potentially causing significant environmental degradation or harmful to human health.
EN
The analysis of the experimental data presented in the present request show that the GMOs in question are harmless to other species of animals, to man and to the environment.
EN
The ProteqFlu vaccine is not potentially risk-causing.
EN
The ProteqFlu vaccine, CTNBio concluded that the present request complies with the pertinent norms and legislation that aim to guarantee the biosafety of the environment, agriculture, human and animal health.
EN
Molecular traditional methods. 
EN
Intercambio de información con otras bases de datos
No
No
Información adicional
ES
Registros que hacen referencia a este documento Mostrar en la búsqueda
Tipo de registro Campo Registro(s)
Decisión o cualquier otra comunicación de un país Evaluación del riesgo 1